World Cancer Day 2023
In 2 days, we will mark World Cancer Day. World Cancer Day is a global uniting initiative led by the Union for International Cancer Control (UICC). It aims to promote awareness …
Aniling owns the GEUS technology, which unifies genetic and epigenetic sequencing and provides end-to-end solutions for the right treatment decisions in oncology. Based on GEUS, Aniling is developing a set of products for cancer diagnostic.
The first Aniling product is the most comprehensive Chronic Lymphocytic Leukemia Next Generation Sequencing diagnostics panel. The GEUS-CLL delivers accurate staging and treatment decisions. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.
In 2 days, we will mark World Cancer Day. World Cancer Day is a global uniting initiative led by the Union for International Cancer Control (UICC). It aims to promote awareness …
Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer in a blood sample. The Aniling -led project uses patented GEUS …